Arbutus Biopharma Corp. (ABUS)

5.15 +0.03 (+0.59%) USD  |  NASDAQ  |  Sep 04, 16:00
5.15 0.00 (0.00%) After-Hours: 20:00
More

Arbutus Biopharma SG&A Expense (TTM) : 16.49M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ABUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 16.49M
March 31, 2026 15.95M
December 31, 2025 15.89M
September 30, 2025 16.92M
June 30, 2025 18.41M
March 31, 2025 22.63M
December 31, 2024 22.11M
September 30, 2024 22.50M
June 30, 2024 23.80M
March 31, 2024 22.24M
December 31, 2023 22.48M
September 30, 2023 21.62M
June 30, 2023 19.27M
March 31, 2023 18.49M
December 31, 2022 17.83M
September 30, 2022 18.28M
June 30, 2022 18.94M
March 31, 2022 18.18M
December 31, 2021 17.14M
September 30, 2021 15.98M
June 30, 2021 15.90M
March 31, 2021 15.02M
December 31, 2020 14.72M
September 30, 2020 13.06M
June 30, 2020 12.24M
Date Value
March 31, 2020 16.87M
December 31, 2019 17.73M
September 30, 2019 21.78M
June 30, 2019 21.16M
March 31, 2019 16.74M
December 31, 2018 16.00M
September 30, 2018 13.62M
June 30, 2018 14.65M
March 31, 2018 15.47M
December 31, 2017 16.13M
September 30, 2017 17.32M
June 30, 2017 17.38M
March 31, 2017 36.55M
December 31, 2016 39.44M
September 30, 2016 43.06M
June 30, 2016 47.04M
March 31, 2016 30.94M
December 31, 2015 26.44M
September 30, 2015 21.17M
June 30, 2015 15.22M
March 31, 2015 9.349M
December 31, 2014 8.683M
September 30, 2014 8.446M
June 30, 2014 7.634M
March 31, 2014 6.701M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Moderna, Inc. 965.00M
Insmed, Inc. 893.58M
Pfizer Inc. 13.72B
Gossamer Bio, Inc. 47.94M
Legend Biotech Corp. 376.01M